Trial Details
COMPLETEDBasic Information
| Clinical ID | c69 |
|---|---|
| Identifier | NCT00486031 |
| Trial Title | Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Disease|Ulcerative Colitis |
| Interventions | DRUG: Balsalazide Disodium |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-06 |
|---|---|
| Primary Completion Date | 2025-04-08 |
| Completion Date | 2025-12-08 |